Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|

Compound research hub

Epithalon: Research, Handling and Batch Documentation

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) from Russian gerontology research, studied for telomerase activation in cell and rodent models and holding no approved indication in Western countries.

Part of Volta's wellness research peptides catalogue.

Identity and research status

Also referred to as
Epitalon, Epithalone, AEDG Peptide, Epithalamin analog
Sequence
Ala-Glu-Asp-Gly (H-Ala-Glu-Asp-Gly-OH)
Single-letter Code
AEDG
Molecular Formula
C14H22N4O9
Molecular Weight
390.35 g/mol
Monoisotopic Mass
390.1387 Da
CAS Number
307297-39-8
PubChem CID
219042
UNII
O65P17785G
ChEBI ID
CHEBI:230091
Also Known As
Epitalon, Epithalone, AEDG peptide
Appearance
White lyophilised powder
XLogP
-5.5
Topological Polar Surface Area
225 square angstroms
Hydrogen Bond Donors / Acceptors
7 / 10
Ionisation at pH 7.4
Net negative, from two free side-chain carboxylates and a free C-terminal carboxyl
Terminal Modifications
None; free N-terminal amine and free C-terminal acid
CAS number
307297-39-8

Evidence level: Preclinical (grade D)

Regulatory status: Research-only / No approved human indication in Western countries

Evidence grades describe the published literature on the compound, not a property of the material Volta supplies, and are not a statement that any use is approved. See how these grades are assigned.

Mechanism, in brief

The finding the compound is known for came from a 2003 experiment in telomerase-negative human fetal fibroblast culture. Adding Epithalon induced expression of the telomerase catalytic subunit, produced measurable telomerase enzymatic activity, and elongated telomeres in cells that had none of that activity to begin with. Treated cultures kept dividing past the 44th passage while controls stopped at the 34th. The interpretation offered was reactivation of a telomerase gene that somatic cells normally keep silent.

  1. Cell entry. AEDG carries three free carboxylates and one free amine, giving it an XLogP of -5.5 and a topological polar surface area of 225 square angstroms. Short peptides of this class are reported to reach the nucleus and nucleolus intact; no transporter has been named.
  2. DNA and histone contact. Modelling places AEDG in the major groove at ATTTC and ATTTTC blocks, including sites in the telomerase promoter region, and on the DNA-contacting arms of histones H1/3 and H1/6.
  3. Chromatin decondensation. In cultured lymphocytes from donors aged 76 to 80, Epitalon activated ribosomal genes and decondensed pericentromeric structural heterochromatin, releasing genes silenced by age-related condensation of euchromatic regions.
  4. hTERT transcription. In normal human fibroblasts and epithelial cells, hTERT mRNA and telomerase enzymatic activity rise dose-dependently after treatment.
  5. Telomere extension. Telomere length increases measurably by qPCR. In telomerase-competent and ALT-competent cancer lines the same length increase occurs by the recombination route instead.

The full research write-up, including the findings behind each claim and the model each came from, is on the Epithalon 10mg 10mg page.

Vial sizes available

Every size of Epithalon Volta lists, in stock or not. Each is a separate catalogue page with its own batch number and specification table.

Purity and batch documentation

Volta's release specification is >99% (HPLC). That is a threshold we set. >99% is the specification every batch is released to. The figure on a certificate is what a laboratory measured for one lot.

No third-party certificate has been published for Epithalonyet. The certificates Volta does publish, with the laboratory's own verification link on each, are in the certificate archive.

Research on Epithalon

Handling and stability

Regulatory context

United States
Not FDA-approved. Removed from FDA Category 2 on April 15, 2026. PCAC review scheduled July 23-24, 2026. Previously classified as Category 2, prohibiting compounding. Research chemical.
Canada
Not approved by Health Canada.
United Kingdom
Not MHRA-approved.

Primary sources

  1. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine (2003). doi:10.1023/a:1025493705728
  2. Al-Dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology (2025). doi:10.1007/s10522-025-10315-x
  3. Al-Dulaimi S, Thomas R, Matta S, Roberts T. Correction: Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology (2025). doi:10.1007/s10522-025-10326-8
  4. Araj SK, Brzezik J, Madra-Gackowska K, Szeleszczuk L. Overview of Epitalon: Highly Bioactive Pineal Tetrapeptide with Promising Properties. International Journal of Molecular Sciences (2025). doi:10.3390/ijms26062691
  5. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Zavarzina NY, Semenchenko AV, Yashin AI. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology (2003). doi:10.1023/a:1025114230714
  6. Anisimov VN, Khavinson VK, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer (2002). doi:10.1002/ijc.10570
  7. Djeridane Y, Khavinson VKh, Anisimov VN, Touitou Y. Effect of a synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) on melatonin secretion by the pineal gland of young and old rats. Journal of Endocrinological Investigation (2003). doi:10.1007/BF03345159
  8. Khavinson VK, Kopylov AT, Vaskovsky BV, Ryzhak GA, Lin'kova NS. Identification of Peptide AEDG in the Polypeptide Complex of the Pineal Gland. Bulletin of Experimental Biology and Medicine (2017). doi:10.1007/s10517-017-3922-8
  9. Khavinson V, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S, Sinjari B. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules (2020). doi:10.3390/molecules25030609
  10. Sinjari B, Diomede F, Khavinson V, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S. Short Peptides Protect Oral Stem Cells from Ageing. Stem Cell Reviews and Reports (2020). doi:10.1007/s12015-019-09921-3
  11. Yue X, Liu SL, Guo JN, Meng TG, Zhang XR, Li HX, Song CY, Wang ZB, Schatten H, Sun QY, Guo XP. Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging (Albany NY) (2022). doi:10.18632/aging.204007
  12. Ullah S, Haider Z, Perera CD, Lee SH, Idrees M, Park S, Kong IK. Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development. Life Sciences (2025). doi:10.1016/j.lfs.2025.123381
  13. Gatta M, Dovizio M, Milillo C, Ruggieri AG, Sallese M, Antonucci I, Trofimov A, Khavinson V, Trofimova S, Bruno A, Ballerini P. The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem Cell Reviews and Reports (2025). doi:10.1007/s12015-025-10911-x
  14. Khavinson V, Shataeva L, Chernova A. DNA double-helix binds regulatory peptides similarly to transcription factors. Neuroendocrinology Letters (2005). PMID 15990728
  15. Khavinson VKh, Tarnovskaya SI, Linkova NS, Pronyaeva VE, Shataeva LK, Yakutseni PP. Short cell-penetrating peptides: a model of interactions with gene promoter sites. Bulletin of Experimental Biology and Medicine (2013). doi:10.1007/s10517-013-1961-3
  16. Khavinson VKh, Lezhava TA, Monaselidze JR, Jokhadze TA, Dvalishvili NA, Bablishvili NK, Trofimova SV. Peptide Epitalon activates chromatin at the old age. Neuroendocrinology Letters (2003). PMID 14647006
  17. Khavinson VK, Izmaylov DM, Obukhova LK, Malinin VV. Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mechanisms of Ageing and Development (2000). doi:10.1016/s0047-6374(00)00217-7
  18. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA. Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats. Cancer Letters (2002). doi:10.1016/s0304-3835(02)00090-3
  19. Kossoy G, Anisimov VN, Ben-Hur H, Kossoy N, Zusman I. Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice. In Vivo (2006). PMID 16634527
  20. Khavinson VKh, Razumovsky MI, Trofimova SV, Razumovskaya AM. Retinoprotective effect of Epithalon in Campbell rats of various ages. Bulletin of Experimental Biology and Medicine (2003). doi:10.1023/a:1024931812822
  21. Korkushko OV, Khavinson VKh, Shatilo VB, Antonyuk-Shcheglova IA. Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging. Bulletin of Experimental Biology and Medicine (2006). doi:10.1007/s10517-006-0365-z
  22. Ivko OM, Linkova NS, Ilina AR, Sharova AA, Ryzhak GA. AEDG peptide regulates human circadian rhythms genes expression during pineal gland accelerated aging. Advances in Gerontology (2020). PMID 33280326
  23. National Center for Biotechnology Information. Epitalon, PubChem Compound Summary CID 219042. PubChem (2026)

More wellness research peptides

Epithalon sits in Volta's wellness research peptides catalogue, alongside the other compounds studied in this area. The whole range is on the full research catalogue, and the library of comparisons and guides is under peptide research.

Research use only. Every compound described on this page is supplied for in-vitro laboratory research. Nothing here is a recommendation for human or veterinary use, a dosing instruction, or a claim that any compound is a treatment for any condition. Published trial figures are reported as what an investigator administered in a named study, never as guidance. Read the full research disclaimer.

Cluster last reviewed: 2026-09-16.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.